Integra LifeSciences
IART
277 hedge funds and large institutions have $5.19B invested in Integra LifeSciences in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 97 increasing their positions, 89 reducing their positions, and 25 closing their positions.
76% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 25
6% more funds holding
Funds holding: 261 → 277 (+16)
9% more repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 89
0.49% more ownership
Funds ownership: 90.91% → 91.4% (+0.49%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $5.27B → $5.19B (-$79.3M)
92% less call options, than puts
Call options by funds: $913K | Put options by funds: $11.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$42.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$15.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$14.8M |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$14.5M |
| 5 |
BlackRock
New York
|
+$7.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$46.4M |
| 2 |
Janus Henderson Group
London,
|
-$26.8M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$10.8M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$9.46M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$7.99M |
IART Hedge Fund Activity: Q4 2021 in Review
277 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2021, worth a combined $5.19B — down 1.5% from $5.27B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IART positions and 25 closed out — a net gain of 19 holders — while 97 added to existing stakes and 89 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $42.6M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $46.4M sold.
- 277 institutional investors held Integra LifeSciences (IART) as of Q4 2021, up from 261 in Q3 2021.
- Funds reported $5.19B of Integra LifeSciences stock for Q4 2021, down 1.5% quarter-over-quarter.
- 44 funds opened new Integra LifeSciences positions in Q4 2021 and 25 closed out, a net change of +19 holders.
- The largest Integra LifeSciences buyer in Q4 2021 was Goldman Sachs, an estimated $42.6M added.
- The largest Integra LifeSciences seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $46.4M sold.
Based on aggregated 13F filings for Q4 2021.